Charles River Laboratories, a leading drug discovery and non-clinical development company, will open a new Charles River Accelerator and Development Lab (CRADL®) location in Philadelphia’s One uCity Square in October 2023. The company’s expansion will provide research support to the region’s life sciences community to facilitate their early drug discovery and preclinical in vivo research.

CRADL® Philadelphia’s grand opening will be held from 4:00-6:00 p.m. on Wednesday, October 18, 2023, at One uCity Square. Charles River is inviting researchers in biotech, academia, and pharma, and the professionals, incubators, and organizations who support their progress to tour the […]

Cell and gene therapy developers worldwide have a new source of support in positioning their therapies for success thanks to the launch of the Cell and Gene Therapy (CGT) Integration Hub by Greater Philadelphia-based Chamber member AmerisourceBergen. The global pharmaceutical solutions company, headquartered in Conshohocken, Pa., announced its CGT Integration Hub on April 24, 2023. The platform-agnostic system, powered by the company’s customer relationship management system, aims to improve connectivity across the cell and gene therapy treatment journey by streamlining the path-to-care process to enable an enhanced patient and provider experience.

Specifically, AmerisourceBergen’s CGT Integration […]

On October 11, 2022, Wilmington, Delaware-based ChristianaCare announced it had spun out its first commercial biotechnology private startup company, CorriXR Therapeutics. The startup will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung.

CorriXR Therapeutics’ close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions the new company to research and develop innovative, patient-centered therapies, the nonprofit health system said in its release. CorriXR Therapeutics will license technology from the Gene Editing Institute and work closely with its […]

Our region’s life sciences ecosystem has three new assets we can all use to amplify the discovery, talent, and momentum in Greater Philadelphia. The first is a study by Econsult ranking Greater Philadelphia #2 in cell and gene therapy compared with 14 U.S. cell and gene therapy clusters. You can read about the research and link to the report here; it was recently featured in the trade publication Cell & Gene. The second is JLL’s  2022 Life Sciences Research Outlook & Cluster Rankings, in […]

In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. Commissioned by the Chamber of Commerce for Greater Philadelphia and researched by economic consulting firm Econsult Solutions, Inc. (ESI), the study compares cell and gene therapy hubs in research infrastructure, human capital, innovation output, commercial activity, and value proposition. The only region ranked higher overall than Philadelphia was Boston. New York and San Francisco were ranked #3 and #4, respectively.

“The Philadelphia region is increasingly attracting new […]